Screener
Alto Neuroscience ANRO Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Alto Neuroscience’s reported figures.
The source filing: Alto Neuroscience’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 7:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001999480-26-000012
FAQ
- What is Alto Neuroscience's enterprise value?
- Alto Neuroscience (ANRO) reported enterprise value of $474.75M in Q1 2026.
- How has Alto Neuroscience's enterprise value changed year-over-year?
- Alto Neuroscience's enterprise value increased by 712.2% year-over-year, from -$77.55M to $474.75M.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Alto Neuroscience's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude